These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4990370)
21. Pyrogenicity of poly I. poly C in rabbits. Lindsay HL; Trown PW; Brandt J; Forbes M Nature; 1969 Aug; 223(5207):717-8. PubMed ID: 5802680 [No Abstract] [Full Text] [Related]
22. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors]. Schmähl D Planta Med; 1968; ():3-12. PubMed ID: 4976078 [No Abstract] [Full Text] [Related]
23. Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878). Dixon RL; Adamson RH Cancer Chemother Rep; 1965 Oct; 48():11-6. PubMed ID: 5834734 [No Abstract] [Full Text] [Related]
24. [On some biological effects of the cytostatic agent verrucarin A]. Rüsch ME; Stähelin H Arzneimittelforschung; 1965 Aug; 15(8):893-7. PubMed ID: 4955716 [No Abstract] [Full Text] [Related]
25. Foot-and-mouth disease virus inhibition induced in mice by synthetic double-stranded RNA (polyriboinosinic and polyribocytidylic acids). Richmond JY; Hamilton LD Proc Natl Acad Sci U S A; 1969 Sep; 64(1):81-6. PubMed ID: 4312754 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of tumor growth by polyinosinic-polycytidylic acid. Levy HB; Law LW; Rabson AS Proc Natl Acad Sci U S A; 1969 Feb; 62(2):357-61. PubMed ID: 4894326 [TBL] [Abstract][Full Text] [Related]
27. Relationship between cell-interaction and antiviral activity of polyriboinosinic acid-polyribocytidylic acid in different cell cultures. De Clercq E; De Somer P J Gen Virol; 1973 Apr; 19(1):113-23. PubMed ID: 4360627 [No Abstract] [Full Text] [Related]
28. Interferon induction and suppression of solid tumor growth in rats by tilorone hydrochloride. Rhoads AR; West WL; Morris HP Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):741-50. PubMed ID: 4356214 [No Abstract] [Full Text] [Related]
33. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments]. Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429 [TBL] [Abstract][Full Text] [Related]
34. [The effect of zymosan on the toxicity and activity of various antitumor preparations]. Veksler IG Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211 [No Abstract] [Full Text] [Related]
35. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313). Németh L; Institóris L; Somfai S; Gál F; Pályi I; Sugár J; Csuka O; Szentirmay Z; Kellner B Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589 [No Abstract] [Full Text] [Related]
36. [Studies on the treatment of malignant tumor with fibroblast-inhibiting agents]. Hiraki K; Kimura I; Kageyama H; Kawanishi K; Moritani Y Gan No Rinsho; 1966 Aug; 12(8):499-511. PubMed ID: 6011017 [No Abstract] [Full Text] [Related]
37. [Effect of a bifunctional derivative of nitrosoalkylurea on the growth of experimetal tumors]. Vasil'eva LS; Gumanov LL; D'iachkovskaia RF; Konovalova NP; Surkova NI Izv Akad Nauk SSSR Biol; 1973; 5():737-9. PubMed ID: 4796871 [No Abstract] [Full Text] [Related]
38. 1,6-Dibromo-1,6-dideoxy-dulcitol: a new antitumoral agent. Kellner B; Németh L; Horváth P; Insitóris L Nature; 1967 Jan; 213(5074):402-3. PubMed ID: 6029531 [No Abstract] [Full Text] [Related]